Lynn S. Ashby
Barrow Neurological Institute(US)Arizona Oncology(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments
Most-Cited Works
- → Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial(2017)1,084 cited
- → Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma(2013)590 cited
- → An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity(2014)264 cited
- → Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539(2017)263 cited
- → Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study(2015)231 cited
- → Association ofMGMTPromoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide(2018)